ConductScience.org, home

Paper650646

Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy.

Montgomery AC and 2 others. J R Soc Med, 1978. Cited by 29 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy. Papers, record 650646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/650646

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical study of recurrence rate and survival time of patients with carcinoma of the breast treated by biopsy excision without any other therapy.
PubMed
Journal
J R Soc Med
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2020-06-11
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Montgomery ACA C
2Greening WPW P
3Levene ALA L

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Adult
Aged
Biopsy
England
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local

Source PubMed

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1883,326Subclavicular biopsy as a guideline for the treatment of breast cancer.World J Surg1977https://conductscience.org/library/papers/883326PubMed
2974,986Ten-year results of the treatment of primary operable breast carcinoma: A summary of 304 patients evaluated by the TNM system.Cancer1976https://conductscience.org/library/papers/974986PubMed
34,624,222Treatment of early breast cancer: a report after ten years of a clinical trial.Br Med J1972https://conductscience.org/library/papers/4624222PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
34,459,500Partial breast irradiation versus whole breast radiotherapy for early breast cancer.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/34459500PubMed
27,425,375Partial breast irradiation for early breast cancer.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/27425375PubMed
3,928,002Current status of conservative surgery and radiotherapy as primary local treatment for early carcinoma of the breast.Breast Cancer Res Treat1985https://conductscience.org/library/papers/3928002PubMed
3,821,341[Technic of breast-saving surgery].Langenbecks Arch Chir1986https://conductscience.org/library/papers/3821341PubMed
382,159Review of general surgery 1978.Postgrad Med J1979https://conductscience.org/library/papers/382159PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/650646

GET https://conductscience.org/api/papers/v1/650646/authors